| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |